Philip Greenberg

Philip Greenberg is a Professor in the Department of Medicine/Oncology Division and in the Department of Immunology at the University of Washington (UW), Head of the Program in Immunology at the Fred Hutchinson Cancer Research Center (FHCRC), and an Investigator of the Parker Institute for Cancer Immunotherapy. The research in his laboratory has focused on: (a) elucidating the immunobiology of T cell responses to tumors and chronic viral infections, including the nature of the target antigens recognized or that evade detection; (b) defining the basis for successful T cell eradication of tumors and chronic viral infections, and/or the reasons for failure to accomplish this, including the cellular and molecular mechanisms responsible for acquisition of T cell dysfunction; (c) assessing the roles of TCR affinity and intracellular signaling modules in determining T cell fate and the nature of T cell responses; and (d) genetic engineering of T cells to enhance the efficacy of adoptive T cell therapy in not only relevant preclinical mouse models but also in human clinical trials in patients with cancer or with chronic viral infections. He obtained his undergraduate degree in Biology at Washington University and M.D. in Medicine at State University of New York.

He has authored more than 280 manuscripts and received many honors including Cancer Research Institute’s William B. Coley Award for Distinguished Research in Tumor Immunology, Society for Immunotherapy of Cancer Richard Smalley Memorial Career Award, American Society of Hematology E. Donnall Thomas Prize for Pioneering Research Achievements in Hematology, and the Precision Medicine World Conference Luminary Award; and he has been elected to numerous honorary societies. He was an elected member of the Board of Directors for the AACR, currently serves on advisory boards for several major cancer centers, and also serves on numerous editorial boards, including Cancer Cell and Cancer Immunology and Immunotherapy, and as an Editor-in-Chief for the AACR journal, Cancer Immunology Research.